Share Price and Basic Stock Data
Last Updated: November 28, 2025, 10:03 am
| PEG Ratio | 0.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AccelerateBS India Ltd operates in the IT Consulting & Software industry, with a current market price of ₹72.4 and a market capitalization of ₹24.9 Cr. The company’s revenue reported for the financial year ending March 2023 was ₹2.80 Cr, which slightly increased to ₹6.78 Cr in March 2024, before marginally declining to ₹6.77 Cr in March 2025. The trailing twelve months (TTM) revenue stood at ₹6.90 Cr, indicating a stable revenue base amidst fluctuations. Quarterly sales figures also reflect a variable trend, with the highest sales recorded at ₹4.08 Cr in March 2024 and the lowest at ₹2.71 Cr in September 2023. The company’s revenue from operations per share has shown a decline from ₹31.59 in March 2024 to ₹19.69 in March 2025, highlighting potential challenges in maintaining sales momentum. Overall, the revenue trajectory suggests a need for strategic initiatives to enhance growth in a competitive market.
Profitability and Efficiency Metrics
Profitability metrics for AccelerateBS India Ltd indicate a mixed performance. The operating profit margin (OPM) stood at 27.76% for March 2025, reflecting a recovery from a low of 6.79% in September 2024. However, the company reported a net profit of ₹0.60 Cr for March 2025, showcasing a gradual improvement from ₹0.58 Cr in March 2023. The net profit margin for the same period was 10.82%, which is relatively robust compared to industry standards. The interest coverage ratio (ICR) is exceptionally high at 568.86x for March 2025, indicating a strong ability to meet interest obligations. The cash conversion cycle (CCC) is reported at 106.21 days, which is a slight increase from previous periods, suggesting potential inefficiencies in managing receivables. Overall, while profitability metrics show positive trends, the company must address operational efficiencies to sustain margins.
Balance Sheet Strength and Financial Ratios
AccelerateBS India Ltd’s balance sheet reflects a strong liquidity position, with a current ratio of 10.62x as of March 2025, indicating ample short-term assets to cover liabilities. The company has no reported borrowings, which positions it favorably compared to peers that often carry significant debt. The return on equity (ROE) stands at 17.6%, while return on capital employed (ROCE) is reported at 22.2%, demonstrating effective utilization of equity and capital. However, the price-to-book value (P/BV) ratio at 9.94x suggests that the stock may be overvalued relative to its net assets, which stood at ₹12.70 per share as of March 2025. The company’s financial ratios, including a net profit margin of 10.82%, indicate operational profitability, but the high P/BV ratio could deter value-focused investors. Overall, the balance sheet portrays strength, yet valuation concerns may arise from high market expectations.
Shareholding Pattern and Investor Confidence
AccelerateBS India Ltd has a stable shareholding structure, with promoters holding 71.02% of the total shares as of September 2025, reflecting strong insider confidence. The public holds 28.99% of the shares, which indicates a relatively low level of public float, potentially limiting liquidity. The total number of shareholders increased from 197 in September 2023 to 357 by September 2025, suggesting growing interest and confidence among retail investors. The company has not reported foreign institutional investors (FIIs) or domestic institutional investors (DIIs), which may limit institutional support. The dividend payout ratio for March 2025 is reported at 47.12%, indicating a commitment to returning value to shareholders. However, the lack of institutional backing could pose risks in terms of volatility and market perception. Overall, the shareholding pattern reflects a strong promoter commitment but raises questions about broader market engagement.
Outlook, Risks, and Final Insight
The outlook for AccelerateBS India Ltd hinges on its ability to navigate revenue fluctuations and maintain profitability amid industry competition. Key strengths include a strong liquidity position, high-interest coverage ratio, and consistent promoter support. However, risks persist, particularly regarding operational efficiency, as indicated by the cash conversion cycle and declining revenue from operations per share. The high P/BV ratio may also present challenges in attracting value-oriented investors. To enhance its market position, AccelerateBS must focus on improving operational efficiencies, driving revenue growth through innovation, and potentially diversifying its investor base. If the company successfully addresses these challenges, it could leverage its strengths to achieve sustainable growth, while failure to do so may hinder its performance in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AccelerateBS India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.35/0.33 | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 40.6 Cr. | 12.8 | 12.9/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 12.5 Cr. | 21.2 | 21.2/14.4 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 36.0 Cr. | 84.6 | 101/17.6 | 17.6 | 38.1 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Industry Average | 120,569.63 Cr | 761.78 | 47.09 | 146.74 | 0.71% | 20.11% | 21.05% | 6.56 |
Quarterly Result
| Metric | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 2.80 | 2.71 | 4.08 | 3.24 | 3.53 |
| Expenses | 2.09 | 2.16 | 2.74 | 3.02 | 2.55 |
| Operating Profit | 0.71 | 0.55 | 1.34 | 0.22 | 0.98 |
| OPM % | 25.36% | 20.30% | 32.84% | 6.79% | 27.76% |
| Other Income | 0.04 | -0.89 | 0.01 | 0.02 | 0.03 |
| Interest | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 |
| Profit before tax | 0.65 | -0.42 | 1.28 | 0.18 | 0.93 |
| Tax % | 10.77% | 30.95% | 53.12% | 27.78% | 35.48% |
| Net Profit | 0.58 | -0.56 | 0.59 | 0.13 | 0.60 |
| EPS in Rs | 1.87 | -1.65 | 1.74 | 0.38 | 1.75 |
Last Updated: May 31, 2025, 7:12 am
Below is a detailed analysis of the quarterly data for AccelerateBS India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 3.53 Cr.. The value appears strong and on an upward trend. It has increased from 3.24 Cr. (Sep 2024) to 3.53 Cr., marking an increase of 0.29 Cr..
- For Expenses, as of Mar 2025, the value is 2.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.02 Cr. (Sep 2024) to 2.55 Cr., marking a decrease of 0.47 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Sep 2024) to 0.98 Cr., marking an increase of 0.76 Cr..
- For OPM %, as of Mar 2025, the value is 27.76%. The value appears strong and on an upward trend. It has increased from 6.79% (Sep 2024) to 27.76%, marking an increase of 20.97%.
- For Other Income, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Sep 2024) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Sep 2024) to 0.08 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.93 Cr.. The value appears strong and on an upward trend. It has increased from 0.18 Cr. (Sep 2024) to 0.93 Cr., marking an increase of 0.75 Cr..
- For Tax %, as of Mar 2025, the value is 35.48%. The value appears to be increasing, which may not be favorable. It has increased from 27.78% (Sep 2024) to 35.48%, marking an increase of 7.70%.
- For Net Profit, as of Mar 2025, the value is 0.60 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Sep 2024) to 0.60 Cr., marking an increase of 0.47 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.75. The value appears strong and on an upward trend. It has increased from 0.38 (Sep 2024) to 1.75, marking an increase of 1.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:04 am
| Metric | Mar 2023n n 7m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Sales | 2.80 | 6.78 | 6.77 | 6.90 |
| Expenses | 2.12 | 4.87 | 5.51 | 4.73 |
| Operating Profit | 0.68 | 1.91 | 1.26 | 2.17 |
| OPM % | 24.29% | 28.17% | 18.61% | 31.45% |
| Other Income | 0.07 | -0.89 | 0.05 | 0.10 |
| Interest | 0.05 | 0.02 | 0.06 | 0.02 |
| Depreciation | 0.06 | 0.15 | 0.14 | 0.13 |
| Profit before tax | 0.64 | 0.85 | 1.11 | 2.12 |
| Tax % | 40.62% | 97.65% | 34.23% | |
| Net Profit | 0.39 | 0.03 | 0.73 | 1.47 |
| EPS in Rs | 1.26 | 0.09 | 2.12 | 4.28 |
| Dividend Payout % | 0.00% | 0.00% | 47.12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 2333.33% |
| Change in YoY Net Profit Growth (%) | 0.00% |
AccelerateBS India Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:01 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 110.80 | 103.90 | 106.21 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 110.80 | 103.90 | 106.21 |
| Working Capital Days | 79.52 | 108.21 | 115.38 |
| ROCE % | 51.15% | 22.18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Diluted EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Cash EPS (Rs.) | 2.53 | 0.81 | 2.25 | 2.96 | 4.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Dividend / Share (Rs.) | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 19.69 | 31.59 | 14.26 | 31.72 | 43.92 |
| PBDIT / Share (Rs.) | 3.64 | 8.94 | 3.81 | 4.29 | 6.79 |
| PBIT / Share (Rs.) | 3.24 | 8.26 | 3.53 | 3.66 | 6.08 |
| PBT / Share (Rs.) | 3.23 | 3.97 | 3.30 | 3.42 | 6.04 |
| Net Profit / Share (Rs.) | 2.13 | 0.14 | 1.97 | 2.33 | 4.15 |
| PBDIT Margin (%) | 18.48 | 28.28 | 26.73 | 13.51 | 15.47 |
| PBIT Margin (%) | 16.46 | 26.14 | 24.74 | 11.54 | 13.83 |
| PBT Margin (%) | 16.43 | 12.56 | 23.11 | 10.78 | 13.75 |
| Net Profit Margin (%) | 10.82 | 0.44 | 13.79 | 7.35 | 9.45 |
| Return on Networth / Equity (%) | 16.79 | 0.78 | 17.70 | 23.33 | 41.50 |
| Return on Capital Employeed (%) | 17.19 | 37.65 | 27.91 | 29.61 | 60.62 |
| Return On Assets (%) | 10.39 | 0.62 | 13.23 | 12.91 | 23.50 |
| Long Term Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.23 | 0.00 |
| Total Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.40 | 0.23 |
| Asset Turnover Ratio (%) | 1.14 | 1.75 | 1.14 | 1.85 | 2.94 |
| Current Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Quick Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 37.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 62.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.39 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 568.86 | 202.15 | 16.40 | 17.82 | 193.42 |
| Interest Coverage Ratio (Post Tax) (X) | 334.18 | 100.28 | 9.46 | 10.70 | 119.14 |
| Enterprise Value (Cr.) | 41.82 | 65.99 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 6.18 | 9.72 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 33.41 | 34.36 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 62.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 9.94 | 17.32 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for AccelerateBS India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 3. It has increased from 0.81 (Mar 24) to 2.53, marking an increase of 1.72.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.69. It has decreased from 31.59 (Mar 24) to 19.69, marking a decrease of 11.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.64. This value is within the healthy range. It has decreased from 8.94 (Mar 24) to 3.64, marking a decrease of 5.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 8.26 (Mar 24) to 3.24, marking a decrease of 5.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.23. This value is within the healthy range. It has decreased from 3.97 (Mar 24) to 3.23, marking a decrease of 0.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 2.13, marking an increase of 1.99.
- For PBDIT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has decreased from 28.28 (Mar 24) to 18.48, marking a decrease of 9.80.
- For PBIT Margin (%), as of Mar 25, the value is 16.46. This value is within the healthy range. It has decreased from 26.14 (Mar 24) to 16.46, marking a decrease of 9.68.
- For PBT Margin (%), as of Mar 25, the value is 16.43. This value is within the healthy range. It has increased from 12.56 (Mar 24) to 16.43, marking an increase of 3.87.
- For Net Profit Margin (%), as of Mar 25, the value is 10.82. This value exceeds the healthy maximum of 10. It has increased from 0.44 (Mar 24) to 10.82, marking an increase of 10.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 0.78 (Mar 24) to 16.79, marking an increase of 16.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 37.65 (Mar 24) to 17.19, marking a decrease of 20.46.
- For Return On Assets (%), as of Mar 25, the value is 10.39. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 10.39, marking an increase of 9.77.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.75 (Mar 24) to 1.14, marking a decrease of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 3. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Quick Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 2. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.51, marking an increase of 37.51.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.61. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 31.61, marking an increase of 31.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 62.49. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 62.49, marking an increase of 62.49.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.39. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 68.39, marking an increase of 68.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 568.86. This value is within the healthy range. It has increased from 202.15 (Mar 24) to 568.86, marking an increase of 366.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 334.18. This value is within the healthy range. It has increased from 100.28 (Mar 24) to 334.18, marking an increase of 233.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 41.82. It has decreased from 65.99 (Mar 24) to 41.82, marking a decrease of 24.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.18. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 6.18, marking a decrease of 3.54.
- For EV / EBITDA (X), as of Mar 25, the value is 33.41. This value exceeds the healthy maximum of 15. It has decreased from 34.36 (Mar 24) to 33.41, marking a decrease of 0.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For Retention Ratios (%), as of Mar 25, the value is 62.48. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 62.48, marking an increase of 62.48.
- For Price / BV (X), as of Mar 25, the value is 9.94. This value exceeds the healthy maximum of 3. It has decreased from 17.32 (Mar 24) to 9.94, marking a decrease of 7.38.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AccelerateBS India Ltd:
- Net Profit Margin: 10.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.19% (Industry Average ROCE: 20.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.79% (Industry Average ROE: 21.05%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 334.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 10.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.5 (Industry average Stock P/E: 47.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 604, Quantum Tower, Mumbai Maharashtra 400064 | investors@acceleratebs.com http://www.acceleratebs.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kunal Arvind Shah | Chairman & Managing Director |
| Mr. Keyur Dipakkumar Shah | Whole Time Director |
| Ms. Ami Keyur Shah | Executive Director & CFO |
| Ms. Ishani Kunal Shah | Executive Director |
| Mr. Krunal Bhupendra Katwala | Ind. Non-Executive Director |
| Mr. Pratik Pravin Doshi | Ind. Non-Executive Director |
| Mr. Hardik Naresh Bagadia | Ind. Non-Executive Director |